⌘K

Login Start Free

Home/Filings/4/0001144204-15-068798

4//SEC Filing

Bionik Laboratories Corp. 4

Accession 0001144204-15-068798

CIK 0001508381operating

View on SEC.gov Company Profile

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:01 PM ET

Size

5.5 KB

Accession

0001144204-15-068798

Insider Transaction Report

Form 4

Period: 2015-11-27

Bionik Laboratories Corp.BNKL

MARKOW LESLIE NADENE

Chief Financial Officer

Transactions

Award
Employee Stock Option (right to buy)
2015-11-27+400,000→ 400,000 total
Exercise: $1.22Exp: 2022-11-27→ Common Stock, par value $0.001 (400,000 underlying)

Footnotes (1)

[F1]The options vest 133,333 on November 27, 2016, 133,333 on November 27, 2017 and 133,334 on November 27, 2018.

Documents

1 file

4
v425977_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Bionik Laboratories Corp.

CIK 0001508381

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001508381

Filing Metadata

Form type: 4
Filed: Nov 30, 7:00 PM ET
Accepted: Dec 1, 4:01 PM ET
Size: 5.5 KB

View on SEC.gov